Dr. Michael Green is an Associate Professor and Vice Chair for Research in the Department of Lymphoma & Myeloma at the University of Texas MD Anderson Cancer Center. Dr. Green has led ground-breaking studies analyzing primary samples from patients receiving CAR T cell therapy to identify cellular features associated with outcome and both acute and chronic toxicities. Dr. Green has led the development of a large patient derived xenograft (PDX) repository at MD Anderson that includes models from post-CAR T relapse tumors that serve as important model systems for this study.
Michael Green PhD
The University of Texas MD Anderson Cancer Center
Houston, Texas
United States